Table 1.
Baseline Characteristics of Study Population
| Baseline Characteristics | All Patients | CBV/LPV/r Group | ATV/LPV/r Group |
|---|---|---|---|
| Total number | 75 | 35 | 40 |
| Female – no. (%) | 10 (13.3) | 5 (14.3) | 5 (12.5) |
| Age (years) (Mean (range)) | 39.1 | 36.6 (25-65) | 41.4 (27-66) |
| CD4 count | |||
| Mean | 220 | 239 | 203 |
| 0-99 cells/mm3 | 12 | 5 | 7 |
| 100-199 cells/mm3 | 20 | 7 | 13 |
| 200-399 cells/mm3 | 40 | 21 | 19 |
| ≥400 cells/mm3 | 3 | 2 | 1 |
| HIV-1 RNA level | 208,463 | 142,422 | 270,836 |
| (Mean (range)) | (745-4,200,000) | (2,623-548,000) | (745-4,200,000) |
| log | 5,319 | 5,154 | 5,433 |
| <50,000 cop/ml | 27 | 13 | 14 |
| 50,000-99,999 cop/ml | 12 | 6 | 6 |
| 100,000-299,999 cop/ml | 26 | 12 | 14 |
| ≥300,000 cop/ml | 10 | 4 | 6 |
| Clinical category | |||
| A | 45 | 22 | 23 |
| B | 24 | 10 | 14 |
| C | 6 | 3 | 3 |